FDA feedback gives Argenica clear path to lift clinical hold on brain drug
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Argenica Therapeutics a question about this update.